# A Study to Evaluate Single and Multiple Doses of SEP-479 in Healthy Adult Participants

> **NCT07433179** · PHASE1 · RECRUITING · sponsor: **Septerna, Inc.** · enrollment: 150 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** SEP-479
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07433179
- **Lead sponsor:** Septerna, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-04
- **Primary completion:** 2027-02
- **Final completion:** 2027-02
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07433179

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07433179, "A Study to Evaluate Single and Multiple Doses of SEP-479 in Healthy Adult Participants". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07433179. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*